Does the media favor NEPH or RMTI?

In the previous week, Nephros had 4 more articles in the media than Rockwell Medical. MarketBeat recorded 5 mentions for Nephros and 1 mentions for Rockwell Medical. Nephros' average media sentiment score of 0.72 beat Rockwell Medical's score of -0.50 indicating that Nephros is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nephros 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Rockwell Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative

Do analysts prefer RMTI or EVTV?

Rockwell Medical presently has a consensus price target of $20.00, indicating a potential upside of 192.40%. Given Rockwell Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Rockwell Medical is more favorable than Envirotech Vehicles. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Envirotech Vehicles 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Does the media prefer RMTI or EVTV?

In the previous week, Rockwell Medical and Rockwell Medical both had 1 articles in the media. Envirotech Vehicles' average media sentiment score of 0.00 beat Rockwell Medical's score of -0.50 indicating that Envirotech Vehicles is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rockwell Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Envirotech Vehicles 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Do analysts rate RMTI or RVP?

Rockwell Medical currently has a consensus target price of $20.00, indicating a potential upside of 192.40%. Given Rockwell Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Retractable Technologies 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Do analysts recommend RMTI or LUCY?

Rockwell Medical currently has a consensus target price of $20.00, indicating a potential upside of 192.40%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Innovative Eyewear. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Rockwell Medical 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Innovative Eyewear 1 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50

Does the media prefer RMTI or LUCY?

In the previous week, Rockwell Medical and Rockwell Medical both had 1 articles in the media. Innovative Eyewear's average media sentiment score of 0.00 beat Rockwell Medical's score of -0.50 indicating that Innovative Eyewear is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Rockwell Medical 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative Innovative Eyewear 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Rockwell Medical (RMTI) Competitors

$6.84 -0.30 (-4.20%)

As of 04:00 PM Eastern

Compare

RMTI vs. NEPH, EVTV, RVP, BMRA, and LUCY

Should you buy Rockwell Medical stock or one of its competitors? Rockwell Medical's main competitors and comparable companies include Nephros (NEPH), Envirotech Vehicles (EVTV), Retractable Technologies (RVP), Biomerica (BMRA), and Innovative Eyewear (LUCY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Rockwell Medical compare to Nephros?

Nephros (NASDAQ:NEPH) and Rockwell Medical (NASDAQ:RMTI) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, media sentiment, valuation and institutional ownership.

41.1% of Nephros shares are owned by institutional investors. Comparatively, 23.3% of Rockwell Medical shares are owned by institutional investors. 6.7% of Nephros shares are owned by company insiders. Comparatively, 4.6% of Rockwell Medical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

In the previous week, Nephros had 4 more articles in the media than Rockwell Medical. MarketBeat recorded 5 mentions for Nephros and 1 mentions for Rockwell Medical. Nephros' average media sentiment score of 0.72 beat Rockwell Medical's score of -0.50 indicating that Nephros is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Nephros	1 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Rockwell Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative

Nephros presently has a consensus target price of $4.00, suggesting a potential downside of 8.68%. Rockwell Medical has a consensus target price of $20.00, suggesting a potential upside of 192.40%. Given Rockwell Medical's higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Nephros.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Nephros	0 Sell rating(s)	3 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Nephros has a beta of 1.51, meaning that its stock price is 51% more volatile than the broader market. Comparatively, Rockwell Medical has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market.

Nephros has higher earnings, but lower revenue than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Nephros, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Nephros	$18.79M	2.53	$1.19M	$0.16	27.38
Rockwell Medical	$69.26M	0.39	-$5.31M	-$1.50	N/A

Nephros has a net margin of 8.38% compared to Rockwell Medical's net margin of -7.98%. Nephros' return on equity of 11.03% beat Rockwell Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Nephros	8.38%	11.03%	8.38%
Rockwell Medical	-7.98%	-15.41%	-9.62%

Summary

Nephros beats Rockwell Medical on 11 of the 15 factors compared between the two stocks.

How does Rockwell Medical compare to Envirotech Vehicles?

Rockwell Medical (NASDAQ:RMTI) and Envirotech Vehicles (NASDAQ:EVTV) are both small-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation.

In the previous week, Rockwell Medical and Rockwell Medical both had 1 articles in the media. Envirotech Vehicles' average media sentiment score of 0.00 beat Rockwell Medical's score of -0.50 indicating that Envirotech Vehicles is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Envirotech Vehicles	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Rockwell Medical has higher revenue and earnings than Envirotech Vehicles. Rockwell Medical is trading at a lower price-to-earnings ratio than Envirotech Vehicles, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.39	-$5.31M	-$1.50	N/A
Envirotech Vehicles	$5.94M	4.24	-$39.13M	-$6.45	N/A

Rockwell Medical has a net margin of -7.98% compared to Envirotech Vehicles' net margin of -382.71%. Rockwell Medical's return on equity of -15.41% beat Envirotech Vehicles' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Envirotech Vehicles	-382.71%	-1,284.22%	-181.53%

Rockwell Medical presently has a consensus price target of $20.00, indicating a potential upside of 192.40%. Given Rockwell Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Rockwell Medical is more favorable than Envirotech Vehicles.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Envirotech Vehicles	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

Rockwell Medical has a beta of 1.6, suggesting that its share price is 60% more volatile than the broader market. Comparatively, Envirotech Vehicles has a beta of 0.85, suggesting that its share price is 15% less volatile than the broader market.

23.3% of Rockwell Medical shares are owned by institutional investors. Comparatively, 5.7% of Envirotech Vehicles shares are owned by institutional investors. 4.6% of Rockwell Medical shares are owned by insiders. Comparatively, 17.8% of Envirotech Vehicles shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Rockwell Medical beats Envirotech Vehicles on 11 of the 15 factors compared between the two stocks.

How does Rockwell Medical compare to Retractable Technologies?

Rockwell Medical (NASDAQ:RMTI) and Retractable Technologies (NYSE:RVP) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their valuation, media sentiment, risk, earnings, analyst recommendations, dividends, institutional ownership and profitability.

In the previous week, Rockwell Medical had 1 more articles in the media than Retractable Technologies. MarketBeat recorded 1 mentions for Rockwell Medical and 0 mentions for Retractable Technologies. Retractable Technologies' average media sentiment score of 0.00 beat Rockwell Medical's score of -0.50 indicating that Retractable Technologies is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Negative
Retractable Technologies	Neutral

Rockwell Medical currently has a consensus target price of $20.00, indicating a potential upside of 192.40%. Given Rockwell Medical's stronger consensus rating and higher possible upside, research analysts plainly believe Rockwell Medical is more favorable than Retractable Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Retractable Technologies	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Rockwell Medical has a net margin of -7.98% compared to Retractable Technologies' net margin of -41.11%. Rockwell Medical's return on equity of -15.41% beat Retractable Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Retractable Technologies	-41.11%	-17.15%	-9.33%

Rockwell Medical has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market. Comparatively, Retractable Technologies has a beta of 1.22, meaning that its stock price is 22% more volatile than the broader market.

Rockwell Medical has higher revenue and earnings than Retractable Technologies. Rockwell Medical is trading at a lower price-to-earnings ratio than Retractable Technologies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.39	-$5.31M	-$1.50	N/A
Retractable Technologies	$37.15M	0.54	-$7.01M	-$0.21	N/A

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 7.6% of Retractable Technologies shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by insiders. Comparatively, 59.5% of Retractable Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Summary

Rockwell Medical beats Retractable Technologies on 10 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Biomerica?

Rockwell Medical (NASDAQ:RMTI) and Biomerica (NASDAQ:BMRA) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, analyst recommendations, valuation, media sentiment, institutional ownership, dividends, profitability and risk.

Rockwell Medical presently has a consensus price target of $20.00, indicating a potential upside of 192.40%. Biomerica has a consensus price target of $9.00, indicating a potential upside of 452.15%. Given Biomerica's higher probable upside, analysts clearly believe Biomerica is more favorable than Rockwell Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Biomerica	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

In the previous week, Rockwell Medical had 1 more articles in the media than Biomerica. MarketBeat recorded 1 mentions for Rockwell Medical and 0 mentions for Biomerica. Biomerica's average media sentiment score of 0.00 beat Rockwell Medical's score of -0.50 indicating that Biomerica is being referred to more favorably in the news media.

Company	Overall Sentiment
Rockwell Medical	Negative
Biomerica	Neutral

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 22.3% of Biomerica shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by insiders. Comparatively, 18.0% of Biomerica shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Biomerica has lower revenue, but higher earnings than Rockwell Medical. Rockwell Medical is trading at a lower price-to-earnings ratio than Biomerica, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.39	-$5.31M	-$1.50	N/A
Biomerica	$5.31M	0.95	-$4.97M	-$0.89	N/A

Rockwell Medical has a beta of 1.6, meaning that its stock price is 60% more volatile than the broader market. Comparatively, Biomerica has a beta of 0.35, meaning that its stock price is 65% less volatile than the broader market.

Rockwell Medical has a net margin of -7.98% compared to Biomerica's net margin of -96.49%. Rockwell Medical's return on equity of -15.41% beat Biomerica's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Biomerica	-96.49%	-98.14%	-70.42%

Summary

Rockwell Medical beats Biomerica on 9 of the 16 factors compared between the two stocks.

How does Rockwell Medical compare to Innovative Eyewear?

Rockwell Medical (NASDAQ:RMTI) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

In the previous week, Rockwell Medical and Rockwell Medical both had 1 articles in the media. Innovative Eyewear's average media sentiment score of 0.00 beat Rockwell Medical's score of -0.50 indicating that Innovative Eyewear is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Rockwell Medical	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Innovative Eyewear	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

23.3% of Rockwell Medical shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 4.6% of Rockwell Medical shares are held by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Rockwell Medical has a beta of 1.6, meaning that its share price is 60% more volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.72, meaning that its share price is 172% more volatile than the broader market.

Rockwell Medical currently has a consensus target price of $20.00, indicating a potential upside of 192.40%. Given Rockwell Medical's stronger consensus rating and higher probable upside, analysts plainly believe Rockwell Medical is more favorable than Innovative Eyewear.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Rockwell Medical	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Innovative Eyewear	1 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.50

Rockwell Medical has a net margin of -7.98% compared to Innovative Eyewear's net margin of -272.42%. Rockwell Medical's return on equity of -15.41% beat Innovative Eyewear's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Rockwell Medical	-7.98%	-15.41%	-9.62%
Innovative Eyewear	-272.42%	-83.37%	-76.02%

Rockwell Medical has higher revenue and earnings than Innovative Eyewear. Rockwell Medical is trading at a lower price-to-earnings ratio than Innovative Eyewear, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Rockwell Medical	$69.26M	0.39	-$5.31M	-$1.50	N/A
Innovative Eyewear	$2.66M	1.68	-$7.59M	-$1.69	N/A

Summary

Rockwell Medical beats Innovative Eyewear on 11 of the 15 factors compared between the two stocks.

Get Rockwell Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RMTI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RMTI vs. The Competition

Export

Metric	Rockwell Medical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$28.31M	$5.82B	$7.02B	$12.98B
Dividend Yield	N/A	1.78%	2.58%	10.20%
P/E Ratio	-4.56	20.21	210.34	20.96
Price / Sales	0.39	61.03	588.78	86.31
Price / Cash	N/A	33.55	28.89	37.42
Price / Book	0.73	6.21	11.27	6.42
Net Income	-$5.31M	$147.87M	$3.45B	$347.03M
7 Day Performance	-5.39%	3.40%	3.56%	2.48%
1 Month Performance	21.93%	1.66%	-0.58%	-1.04%
1 Year Performance	-28.99%	6.26%	77.52%	23.22%

Rockwell Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RMTI Rockwell Medical	3.091 of 5 stars	$6.84 -4.2%	$20.00 +192.4%	-25.9%	$28.31M	$69.26M	N/A	300	Upcoming Earnings Gap Up High Trading Volume
NEPH Nephros	2.9873 of 5 stars	$3.59 +2.4%	$5.00 +39.1%	+7.9%	$38.50M	$18.79M	50.65	30	Earnings Report Gap Up
EVTV Envirotech Vehicles	0.0834 of 5 stars	$1.95 +0.3%	N/A	+9.3%	$25.16M	$5.94M	N/A	10
RVP Retractable Technologies	N/A	$0.67 +0.7%	N/A	-13.5%	$19.91M	$37.15M	N/A	240
BMRA Biomerica	1.8789 of 5 stars	$1.51 -1.6%	$9.00 +498.0%	-47.1%	$4.65M	$5.31M	N/A	60	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RMTI) was last updated on 8/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, EVTV, RVP, BMRA, and LUCY

How does Rockwell Medical compare to Nephros?

Summary

How does Rockwell Medical compare to Envirotech Vehicles?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Summary

How does Rockwell Medical compare to Biomerica?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Rockwell Medical (RMTI) Competitors

RMTI vs. NEPH, EVTV, RVP, BMRA, and LUCY

How does Rockwell Medical compare to Nephros?

Do institutionals and insiders hold more shares of NEPH or RMTI?

Does the media favor NEPH or RMTI?

Do analysts recommend NEPH or RMTI?

Which has more risk & volatility, NEPH or RMTI?

Which has higher earnings and valuation, NEPH or RMTI?

Is NEPH or RMTI more profitable?

Summary

How does Rockwell Medical compare to Envirotech Vehicles?

Does the media prefer RMTI or EVTV?

Which has preferable earnings and valuation, RMTI or EVTV?

Is RMTI or EVTV more profitable?

Do analysts prefer RMTI or EVTV?

Which has more risk & volatility, RMTI or EVTV?

Do institutionals and insiders believe in RMTI or EVTV?

Summary

How does Rockwell Medical compare to Retractable Technologies?

Does the media refer more to RMTI or RVP?

Do analysts rate RMTI or RVP?

Is RMTI or RVP more profitable?

Which has more risk & volatility, RMTI or RVP?

Which has stronger earnings & valuation, RMTI or RVP?

Do institutionals & insiders hold more shares of RMTI or RVP?

Summary

How does Rockwell Medical compare to Biomerica?

Do analysts rate RMTI or BMRA?

Does the media prefer RMTI or BMRA?

Do institutionals and insiders hold more shares of RMTI or BMRA?

Which has better earnings and valuation, RMTI or BMRA?

Which has more volatility & risk, RMTI or BMRA?

Is RMTI or BMRA more profitable?

Summary

How does Rockwell Medical compare to Innovative Eyewear?

Does the media prefer RMTI or LUCY?

Do insiders and institutionals hold more shares of RMTI or LUCY?

Which has more volatility and risk, RMTI or LUCY?

Do analysts recommend RMTI or LUCY?

Is RMTI or LUCY more profitable?

Which has higher valuation and earnings, RMTI or LUCY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RMTI vs. The Competition

Rockwell Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools